Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-22

FDA Approved: LOFEXIDINE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals, Inc.'s original Abbreviated New Drug Application to market a generic lofexidine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOFEXIDINE (LOFEXIDINE)

Snippet

ORIG AP for LOFEXIDINE (LOFEXIDINE)